BEIJING, Sept. 18, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter, dated

ORANGE and LOS ANGELES Counties, Calif., Sept. 18, 2019 /PRNewswire/ -- MemorialCare Research Program has been awarded accreditation by the Association of Human

BIRMINGHAM, Ala., Sept. 18, 2019 /PRNewswire/ -- Therapy Brands is pleased to welcome and announce Ryan Anschuetz as the Vice President of Sales. Anschuetz

HARTFORD, Conn., Sept. 18, 2019 /PRNewswire/ --WHAT:  Fifth Annual Connecticut Behavioral Health Plan (C

NORTHBROOK, Ill., Sept. 18, 2019 /PRNewswire/ -- Nearly 1,000 Astellas employees stepped away from the office today to volunteer across the United States as part of the 10th annual Changing Tomorrow Day. On Changing Tomorrow Day (#ChangingTomorrow)—Astellas' global day of service—employees volunteered together at 16 diver

WASHINGTON, Sept. 18, 2019 /PRNewswire/ -- Today the National Safety Council (NSC) made specific asks of the American business community and unveiled a new toolkit that employers can u

MENLO PARK, Calif., Sept. 18, 2019 /PRNewswire/ -- Sight Sciences announced clinical results from the first study of the OMNI® Surgical System in glaucoma patients were presented at the European Society of Cataract and Refractive Surgery (ESCRS). Findings from the pilot study suggest the OMNI® Surgical System, which is dually indicated in

MANHASSET, N.Y., Sept. 18, 2019 /PRNewswire/ -- The Feinstein Institutes for Medical Research hosted a Marsh Lecture by a professor of neurological surge

SAN DIEGO, Sept. 18, 2019 /PRNewswire/ -- CannVerify LLC, the leader in brand protection and customer connection for the Cannabis and Hemp industries, announced that their proprietary blockchain based solution has been effectively applied to protect consumers from counterfeits on nearly 1 million products. The solution effectively counteract

WASHINGTON, Sept. 18, 2019 /PRNewswire/ -- Pharmaceutical Manufacturing Research Services, Inc. (PMRS), a leading maker of pharmaceuticals for industry, has filed a petition asking the U.S. Court of Appeals for the District of Columbia Circuit to overturn the U.S. Food and Drug Administration's refusal to approve a new opioid capsule intended to